Start-ups presented their ideas at the “Munich Demo Day” of the BioTech Bootcamp BioM and SmiLe
As part of this year's BioTech Bootcamp of BioM Biotech Cluster Development GmbH and the life science business incubator…
As part of this year's BioTech Bootcamp of BioM Biotech Cluster Development GmbH and the life science business incubator…
The new cGMP filling line at Lonza’s Stein (CH) site will enable handling and filling of bioconjugates for commercia…
In April 2021, the FDA approved the 100th monoclonal antibody as a therapeutic entity, a milestone that took 35 years to…
Eckert & Ziegler (ISIN DE0005659700, TecDAX) and a subsidiary of POINT Biopharma Global Inc. (“POINT”, NASDAQ: PNT) have…
Promising top-line results warrant focus of the clinical development on NOX-A12 combination therapies in brain cancer NO…
First subject vaccinated in Phase 3 clinical trial evaluating potential of the VLP-based candidate, ABNCoV2 as a booster…
Bavarian Nordic A/S (OMX: BAVA) announced today that the European Medicines Agency (EMA) has granted access to its prior…
Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ2 publis…
A rapid antigen test provides a fast and reliable indication of the presence of the SARS-CoV-2 virus, the causative agen…
4SC today announced the initiation of a second clinical collaboration with the Netherlands Cancer Institute (NKI) on a p…